Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis

Tumor necrosis factor alpha (TNF-alpha) is a macrophage/monocyte-derived polypeptide which modulates the expression of various genes in vascular endothelial cells and induces angiogenesis. However, the underlying mechanism by which TNF-alpha mediates angiogenesis is not completely understood. In this study, we assessed whether TNF-alpha-induced angiogenesis is mediated through TNF-alpha itself or indirectly through other TNF-alpha-induced angiogenesis-promoting factors. Cellular mRNA levels of interleukin-8 (IL-8), vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and their receptors were increased after the treatment of human microvascular endothelial cells with TNF-alpha (100 U/ml). TNF-alpha-dependent tubular morphogenesis in vascular endothelial cells was inhibited by the administration of anti-IL-8, anti-VEGF, and anti-bFGF antibodies, and coadministration of all three antibodies almost completely abrogated tubular formation. Moreover, treatment with Sp1, NF-kappaB, and c-Jun antisense oligonucleotides inhibited TNF-alpha-dependent tubular morphogenesis by microvascular endothelial cells. Administration of a NF-kappaB antisense oligonucleotide almost completely inhibited TNF-alpha-dependent IL-8 production and partially abrogated TNF-alpha-dependent VEGF production, and an Sp1 antisense sequence partially inhibited TNF-alpha-dependent production of VEGF. A c-Jun antisense oligonucleotide significantly inhibited TNF-alpha-dependent bFGF production but did not affect the production of IL-8 and VEGF. Administration of an anti-IL-8 or anti-VEGF antibody also blocked TNF-alpha-induced neovascularization in the rabbit cornea in vivo. Thus, angiogenesis by TNF-alpha appears to be modulated through various angiogenic factors, both in vitro and in vivo, and this pathway is controlled through paracrine and/or autocrine mechanisms.

[1]  H Ueno,et al.  The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. , 1992, Science.

[2]  庄野禎久.  Involvement of the Transcription Factor NF-кB in Tubular Morphogenesis of Human Microvascular Endothelial Cells by Oxidative Stress(酸化ストレスによって誘導されるヒト微小血管内皮細胞の管腔様構造形成に転写因子NF-κBが関与している) , 1998 .

[3]  R. Hamanaka,et al.  Endogenous basic fibroblast growth factor-dependent induction of collagenase and interleukin-6 in tumor necrosis factor-treated human microvascular endothelial cells. , 1991, The Journal of biological chemistry.

[4]  L. Pusztai,et al.  Expression of tumour necrosis factor alpha and its receptors in carcinoma of the breast. , 1994, British Journal of Cancer.

[5]  Mayumi Ono,et al.  Induction of Vascular Endothelial Growth Factor by Tumor Necrosis Factor α in Human Glioma Cells , 1996, The Journal of Biological Chemistry.

[6]  K. Kohno,et al.  The exogenous control of transfected c-fos gene expression and angiogenesis in cells implanted into the rat brain , 1995, Brain Research.

[7]  T. Sekine,et al.  Identification of a new serine kinase that activates NF kappa B by direct phosphorylation. , 1993, The Journal of biological chemistry.

[8]  R. Strieter,et al.  Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.

[9]  A. Passaniti,et al.  A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[10]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[11]  K. Kohno,et al.  Indispensable role of tissue-type plasminogen activator in growth factor-dependent tube formation of human microvascular endothelial cells in vitro. , 1993, Experimental cell research.

[12]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[13]  H. Izumi,et al.  Cross talk of tumor necrosis factor-alpha and epidermal growth factor in human microvascular endothelial cells. , 1994, Experimental cell research.

[14]  D. Connolly,et al.  Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration , 1990, The Journal of experimental medicine.

[15]  S D Prionas,et al.  Dual role of tumor necrosis factor-alpha in angiogenesis. , 1992, The American journal of pathology.

[16]  W. Fiers,et al.  Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. , 1986, Journal of immunology.

[17]  H. Izumi,et al.  Morphological change and destabilization of beta-actin mRNA by tumor necrosis factor in human microvascular endothelial cells. , 1993, Experimental cell research.

[18]  N. Abraham,et al.  The role of NF-kappaB in the angiogenic response of coronary microvessel endothelial cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  E. Haber,et al.  Cloning and Functional Analysis of the Promoter for KDR/flk-1, a Receptor for Vascular Endothelial Growth Factor(*) , 1995, The Journal of Biological Chemistry.

[20]  P. Libby,et al.  Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. , 1986, The American journal of pathology.

[21]  W. Greene,et al.  Tumor necrosis factor alpha induces proteins that bind specifically to kappa B-like enhancer elements and regulate interleukin 2 receptor alpha-chain gene expression in primary human T lymphocytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Gospodarowicz,et al.  Tumor necrosis factor inhibits the proliferation of cultured capillary endothelial cells. , 1987, Biochemical and biophysical research communications.

[23]  D. Dimitrov,et al.  Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. , 1992, Biochemical and biophysical research communications.

[24]  M. Reitz,et al.  Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Bates,et al.  Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression. , 1990, Biochemistry.

[26]  N. Ida,et al.  A highly sensitive enzyme-linked immunosorbent assay for the measurement of interleukin-8 in biological fluids. , 1992, Journal of immunological methods.

[27]  J O McGee,et al.  Cytokine regulation of angiogenesis in breast cancer: the role of tumor‐associated macrophages , 1995, Journal of leukocyte biology.

[28]  P. Baeuerle,et al.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.

[29]  A. Harris,et al.  Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. , 1996, Cancer research.

[30]  T. Shono,et al.  Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress , 1996, Molecular and cellular biology.

[31]  K. Matsushima,et al.  Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. , 1989, Journal of immunology.

[32]  J. Saffer,et al.  Developmental expression of Sp1 in the mouse , 1991, Molecular and cellular biology.

[33]  Yasuhiko Hayashi,et al.  Possible Participation of Autocrine and Paracrine Vascular Endothelial Growth Factors in Hypoxia-induced Proliferation of Endothelial Cells and Pericytes (*) , 1995, The Journal of Biological Chemistry.

[34]  L. Silengo,et al.  Tumor necrosis factor alpha and interferon gamma modulate the expression of the vitronectin receptor (integrin beta 3) in human endothelial cells. , 1991, The Journal of biological chemistry.

[35]  R. Hamanaka,et al.  Induction of low density lipoprotein receptor and a transcription factor SP-1 by tumor necrosis factor in human microvascular endothelial cells. , 1992, The Journal of biological chemistry.

[36]  M. Jaye,et al.  Cloning and expression of two distinct high‐affinity receptors cross‐reacting with acidic and basic fibroblast growth factors. , 1990, The EMBO journal.

[37]  K. Kohno,et al.  Effects of tumor necrosis factor and epidermal growth factor on cell morphology, cell surface receptors, and the production of tissue inhibitor of metalloproteinases and IL-6 in human microvascular endothelial cells. , 1989, Journal of immunology.

[38]  P. Scheurich,et al.  TNF signal transduction and TNF-responsive genes. , 1992, Immunology series.

[39]  L. Ellis,et al.  The implications of angiogenesis for the biology and therapy of cancer metastasis , 1994, Cell.

[40]  R. Florkiewicz,et al.  Functional characterization of the human basic fibroblast growth factor gene promoter. , 1991, Growth factors.

[41]  G. Nabel,et al.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[42]  L. Chess,et al.  Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1 , 1986, The Journal of experimental medicine.

[43]  W. Risau,et al.  Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[44]  A. Ullrich,et al.  High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis , 1993, Cell.

[45]  T. Okamoto,et al.  Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. , 1993, The Journal of biological chemistry.

[46]  G. Camussi,et al.  Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis , 1994, The Journal of experimental medicine.

[47]  A. Pandey,et al.  Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis. , 1995, Science.

[48]  R. Strieter,et al.  Human corneal interleukin-8. IL-1 and TNF-induced gene expression and secretion. , 1991, The American journal of pathology.

[49]  B. Franza,et al.  In vitro study of functional involvement of Sp1, NF-kappa B/Rel, and AP1 in phorbol 12-myristate 13-acetate-mediated HIV-1 long terminal repeat activation. , 1994, The Journal of biological chemistry.

[50]  M. Kuwano,et al.  Induction of human microvascular endothelial tubular morphogenesis by human keratinocytes: involvement of transforming growth factor-alpha. , 1992, Biochemical and biophysical research communications.

[51]  M. Krönke,et al.  TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced “Acidic” sphingomyelin breakdown , 1992, Cell.

[52]  I. Hemo,et al.  In vivo angiogenic activity of interleukins. , 1990, Archives of ophthalmology.

[53]  G. Camussi,et al.  Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha. , 1988, The Journal of biological chemistry.

[54]  J. Folkman,et al.  Angiogenic factors. , 1987, Science.

[55]  N. Sato,et al.  Tumor necrosis factor inhibiting angiogenesis in vitro. , 1987, Journal of the National Cancer Institute.

[56]  T. Shono,et al.  Dual Pathways to Tubular Morphogenesis of Vascular Endothelial Cells by Human Glioma Cells: Vascular Endothelial Growth Factor/Basic Fibroblast Growth Factor and Interleukin‐8 , 1995, Japanese journal of cancer research : Gann.

[57]  A. Fauci,et al.  Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[58]  T. Cruz,et al.  Involvement of Reactive Oxygen Species in Cytokine and Growth Factor Induction of c-fos Expression in Chondrocytes(*) , 1995, The Journal of Biological Chemistry.

[59]  W I Wood,et al.  Structure and functional expression of a human interleukin-8 receptor. , 1991, Science.

[60]  H. Shepard,et al.  Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α , 1987, Nature.

[61]  K. Kohno,et al.  A model system for tumor angiogenesis: involvement of transforming growth factor-alpha in tube formation of human microvascular endothelial cells induced by esophageal cancer cells. , 1992, Biochemical and biophysical research communications.

[62]  G. Nabel,et al.  A cooperative interaction between NF‐kappa B and Sp1 is required for HIV‐1 enhancer activation. , 1993, The EMBO journal.

[63]  S. Kondo,et al.  Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody. , 1993, Biochemical and biophysical research communications.

[64]  K. Kohno,et al.  Tumor necrosis factor and epidermal growth factor modulate migration of human microvascular endothelial cells and production of tissue-type plasminogen activator and its inhibitor. , 1991, Experimental cell research.

[65]  P. Murphy,et al.  Cloning of complementary DNA encoding a functional human interleukin-8 receptor. , 1991, Science.

[66]  J. Fiddes,et al.  The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. , 1991, The Journal of biological chemistry.

[67]  P. Gullino,et al.  Neovascularization induced by intraocular xenografts of normal, preneoplastic, and neoplastic mouse mammary tissues. , 1976, Journal of the National Cancer Institute.

[68]  K. Kohno,et al.  Induction of vascular endothelial tubular morphogenesis by human glioma cells. A model system for tumor angiogenesis. , 1993, The Journal of clinical investigation.

[69]  C. McClain,et al.  Tumor necrosis factor reduces proteoglycan synthesis in cultured endothelial cells , 1995, Journal of cellular physiology.